Sphera Funds Management Ltd. Glycomimetics Inc Transaction History

Sphera Funds Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	BUY	$9.96 - $13.44 $597,600 - $806,400	60,000 Added 23.9%	311,013 $3.88 Million
Q3 2018 Nov 14, 2018	BUY	$13.7 - $17.12 $151,796 - $189,689	11,080 Added 4.62%	251,013 $3.62 Million
Q2 2018 Aug 13, 2018	BUY	$14.63 - $19.19 $1.32 Million - $1.73 Million	89,933 Added 59.96%	239,933 $3.87 Million
Q1 2018 May 10, 2018	SELL	$16.06 - $25.35 $2.81 Million - $4.44 Million	-175,000 Reduced 53.85%	150,000 $2.44 Million
Q4 2017 Feb 12, 2018	BUY	$10.51 - $17.22 $3.42 Million - $5.6 Million	325,000	325,000 $5.46 Million

36.8M

969K

636K

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $14.7M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.